Difference between revisions of "Amyloid beta A4 peptide"
| Line 53: | Line 53: | ||
|- | |- | ||
| Video | | Video | ||
| − | |{{#ev:youtube|5uXxe-K0uxw}} | + | |{{#ev:youtube|5uXxe-K0uxw|100}} |
|- | |- | ||
| {{infobox header}} | | | {{infobox header}} | | ||
Revision as of 13:11, 4 September 2007
| Template:Infobox header| Amyloid beta A4 peptide | |
|---|---|
| |
| Substrate peptide name | Amyloid beta A4 peptide |
| Synonyms | Alzheimer disease amyloid protein |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Extracellular; cerebrospinal fluid
Alzheimer's disease neuritic plaques |
| Swissprot ID | P05067 |
| Reactive glutamines | Q15 |
| Reactive lysines | K16, K28 |
| Substrate sequence | YEVHHQKLVFFA
DVGSNKGAIIG |
| Structure | 1AML |
| Surface accessibility | ASAView pdf
ASAView txt |
| Disorder prediction | IUPred |
| Reference | PMID:7905838 |
| Notes | |
| Video | 5uXxe-K0uxw|100}} |
| Template:Infobox header | | |
